Vivos Therapeutics, Inc. Deferred Tax Liabilities, Goodwill
Vivos Therapeutics, Inc. (VVOS) had Deferred Tax Liabilities, Goodwill of $12.00 thousand as of 2023-12-31, per its 10-K/A filed 2024-07-30.
Discontinued › Notes › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill · last filed 2024-07-30
- 2023-12-31: Deferred Tax Liabilities, Goodwill $12.00K.
| Period end | Deferred Tax Liabilities, Goodwill |
|---|---|
| 2023-12-31 | $12.00K 10-K/A · filed 2024-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |